CRISPR Gene Editing can Stop Progression of Triple-negative Breast Cancer
Chennai, Aug. 29 -- Highlights
* Targeted, in vivo CRISPR gene therapy is used to stall the progress of triple-negative breast cancer
* Triple-negative breast cancer (TNBC) lacking in estrogen, //progesterone and HER2 receptors is the deadliest of all breast cancers with the highest mortality rates
* This aggressive metastatic cancer has limited treatment options confined to surgery, chemotherapy and radiation
* CRISPR genome editing was used in vivo through an injection into live mice with TNBC
CRISPR gene editing technique can now stop the progression of breast cancer, especially Triple-negative breast cancer (TNBC). CRISPR gene editing is safe in treating pediatric cancers as well, reveals a new study.
Facts About Triple-negative...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.